2025 · Aug 15
Introduced model that scored 100% on USMLE exams
OpenEvidence
🇺🇸🇺🇸 United StatesDecacornAI-Powered Clinical Decision Support for Doctors
80
Overall score
31
Heat score
Pricing
No pricing plans published yet.
Technical Specs
Inputs
Text Prompt, Medical Query, Research Paper, Clinical Data
Outputs
Medical Answers, Summaries, Explanations, Decision Support
AI Type
['Generative AI', 'LLM']
Model Architecture
N/A
Daily Prompts
N/A
Context Length
N/A
Output Quality
Accuracy
80%
Content
80%
Reasoning
80%
Company Profile
Company
OpenEvidence
Founded
2021
HQ
Miami Beach, Florida
Employees
N/A
Total Raised / Total Funding
$700M
Revenue
N/A
Valuation
$12B
ARR
N/A
CEO
Daniel Nadler
Overview
Estimated Paid Users
N/A
Current estimate
Total Earnings Till Date
N/A
No monthly delta yet
Market Share
N/A
Current share
Average Session
N/A
Per active user
Hallucination Rate
80%
Model quality signal
Growth Rate
N/A
Monthly active users
Burn Rate
N/A
Total expenses / years active
Paid User Gain
N/A
Monthly paid user trend
Performance Metrics
Accuracy
80%
Context
80%
Reasoning
80%
Safety
80%
Benchmarks
No benchmark scores available.
OpenEvidence Models
Latest LLM
Type: LLM
Description: First LLM to score 100% on USMLE
Funding Rounds & Investors
Total Funding
$700M
Rounds
1
Series A
$1BJan 2022
source: Crunchbase
Founders/Team
DN
Daniel Nadler
CEO
Direct competitors
No direct competitors available.
Change Log / Major Updates
2026 · Mar 16
Partnered with American Academy of Otolaryngology to update clinical guidelines
Compliance, Integrations & Support
Industry: Not specified
Compliances: Not specified
Integrations: Not specified
Support:Email
Target audience: Physicians, Doctors, Healthcare Professionals, Medical Researchers, Clinicians, Medical Students
Supported languages: English
OpenEvidence Acquisitions
No acquisition records available.
Reviews & Rating
0 reviews
No reviews yet
Be the first to share how OpenEvidence performs for your workflow.
0.0
Accuracy
0.0
Ease of Use
0.0
Output Quality
0.0
Security
0.0
Social Feed
No social feed available for this tool yet.
More About OpenEvidence
OpenEvidence FAQ's
No FAQs available.